Thirona is a global company specializing in advanced AI-powered analysis of thoracic imaging. Built on robust segmentation and precise quantification of bronchial, parenchymal, and vascular lung structures, the LungQ® portfolio delivers automated, accurate assessments across pulmonary diseases. Validated in 250+ peer-reviewed publications, LungQ® provides reliable, reproducible results spanning diverse populations and disease severities. Developed in collaboration with research institutes, academic hospitals, pharmaceutical innovators, and MedTech partners, Thirona’s solutions are used to accelerate imaging-based respiratory clinical trials and advance minimally invasive interventions. Today, LungQ® is installed in 1,200+ hospitals worldwide, contributing to progress in precision medicine for lung disease.